Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 2,264,558 |
|
|||||
| News | - | ||||||
| Day High | 1.35 | Low High |
|||||
| Day Low | 1.29 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Akebia Therapeutics Inc | AKBA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0001 | -0.01% | 1.3299 | 15:48:31 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.32 | 1.29 | 1.35 | 1.33 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,584 | 2,264,558 | $ 1.32 | $ 2,991,972 | - | 0.682 - 2.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:48:41 | 63 | $ 1.32 | USD |
Akebia Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 276.37M | 209.37M | - | 194.62M | -51.93M | -0.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Akebia Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AKBA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.35 | 1.41 | 1.29 | 1.36 | 2,222,575 | -0.0201 | -1.49% |
| 1 Month | 1.875 | 1.93 | 1.29 | 1.50 | 4,478,494 | -0.5451 | -29.07% |
| 3 Months | 1.71 | 2.48 | 1.29 | 1.70 | 4,999,727 | -0.3801 | -22.23% |
| 6 Months | 0.81 | 2.48 | 0.7801 | 1.59 | 3,188,298 | 0.5199 | 64.19% |
| 1 Year | 0.712 | 2.48 | 0.682 | 1.44 | 2,496,315 | 0.6179 | 86.78% |
| 3 Years | 3.05 | 4.33 | 0.241 | 1.32 | 3,774,837 | -1.72 | -56.40% |
| 5 Years | 6.48 | 13.78 | 0.241 | 2.42 | 3,487,253 | -5.15 | -79.48% |
Akebia Therapeutics Description
| Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States. |
